Dies ist eine Übersichtsseite mit Metadaten zu dieser wissenschaftlichen Arbeit. Der vollständige Artikel ist beim Verlag verfügbar.
Appropriateness of ChatGPT in answering heart failure related questions
14
Zitationen
6
Autoren
2023
Jahr
Abstract
Abstract Introduction Heart failure requires complex management with increased patient knowledge shown to improve outcomes. This study assessed the knowledge of Chat Generative Pre-Trained Transformer (ChatGPT) and its appropriateness as a supplemental resource of information for patients with heart failure. Materials and Methods A total of 107 frequently asked heart failure-related questions were included. Responses were generated using GPT-3.5 and GPT-4. The accuracy and reproducibility of responses were graded by two reviewers board-certified in cardiology, with differences resolved by a third reviewer board-certified in cardiology and advanced heart failure. Accuracy was graded using a four-point scale: 1) Comprehensive 2) Correct but inadequate 3) Some correct and some incorrect 4) Completely incorrect. Results GPT-4 displayed a greater proportion of comprehensive knowledge for the categories of “basic knowledge” and “management” (89.8%, 82.9%). GPT-3.5 performed best in the “management” and “other” category (prognosis, procedures, and support) (78.1%, 94.1%). There were two total responses (1.9%) graded as “some correct and incorrect” for GPT-3.5, while no “completely incorrect” responses were produced. The models also provided highly reproducible responses, with GPT-3.5 scoring above 94% in every category and GPT-4 with 100% for all answers. Conclusions GPT-3.5 and GPT-4 answered the majority of heart failure-related questions accurately and reliably. ChatGPT may lead to better outcomes in patients with heart failure by providing accessible and easy to understand health education. However, in its current state the model necessitates further rigorous testing and validation to ensure patient safety and equity across all patient demographics.
Ähnliche Arbeiten
Corrigendum to: 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: Developed by the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) With the special contribution of the Heart Failure Association (HFA) of the ESC.
2021 · 19.535 Zit.
2013 ACCF/AHA Guideline for the Management of Heart Failure
2013 · 12.581 Zit.
2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
2021 · 12.088 Zit.
Should We STOP Angiotensin Converting Enzyme Inhibitors/Angiotensin Receptor Blockers in Advanced Kidney Disease?
2016 · 11.730 Zit.
K/DOQI clinical practice guidelines for chronic kidney disease: Evaluation, classification, and stratification
2002 · 11.655 Zit.